Early results for active infective endocarditis
- PMID: 29881490
- PMCID: PMC5989182
- DOI: 10.11604/pamj.2017.28.245.13518
Early results for active infective endocarditis
Abstract
Introduction: Cardiac surgery is frequently needed during active phase of infective endocarditis (IE). The purpose of this study was to analyze the immediate and late results and determine the risk factors for death.
Methods: We retrospectively reviewed 101 patients with IE operated in the active phase. The mean age was 40.5 ± 12.5 years. 16 patients (15.8%) were diagnosed with prosthetic valve endocarditis (PVE). 81 (80.9%) were in NYHA functional class III-IV. Blood cultures were positive in only 24 cases (23.9%).
Results: in-hospital mortality rate was 17.9% (18 cases). Multivariate analysis indentified five determinant predictor factors: congestive heart failure (CHF), renal insufficiency, high Euroscore, prolonged cardiopulmonary bypass time (> 120 min) and long ICU stay. The median follow-up period was 4.2 (2-6.5) years. Overall survival rate for all patients who survived surgery was 97% at 5 years and 91% at 10 years.
Conclusion: Despite high in-hospital mortality rate, when patients receive operation early in the active phase of their illness, late outcome may be good.
Keywords: Infective endocarditis; active phase; valvular surgery.
Similar articles
-
Surgery for prosthetic valve endocarditis: associations between morbidity, mortality and costs.Interact Cardiovasc Thorac Surg. 2016 Jun;22(6):784-91. doi: 10.1093/icvts/ivw035. Epub 2016 Mar 9. Interact Cardiovasc Thorac Surg. 2016. PMID: 26965513 Free PMC article.
-
Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients.Intensive Care Med. 2004 Nov;30(11):2046-52. doi: 10.1007/s00134-004-2436-9. Epub 2004 Sep 15. Intensive Care Med. 2004. PMID: 15372147
-
Surgery for prosthetic valve endocarditis: a retrospective study of a national registry.Eur J Cardiothorac Surg. 2017 Jul 1;52(1):105-111. doi: 10.1093/ejcts/ezx045. Eur J Cardiothorac Surg. 2017. PMID: 28329161
-
Surgical management of Staphylococcus capitis prosthetic valve infective endocarditis: Retrospective review of a 10-year single center experience and review of the literature.J Infect Public Health. 2020 Nov;13(11):1705-1709. doi: 10.1016/j.jiph.2020.09.010. Epub 2020 Oct 11. J Infect Public Health. 2020. PMID: 33055006 Review.
-
Native and prosthetic valve infective endocarditis: clinicopathologic correlation and review of the literature.Malays J Pathol. 2014 Aug;36(2):71-81. Malays J Pathol. 2014. PMID: 25194529 Review.
References
-
- Carapetis JR. Rheumatic heart disease in Asia. Circulation. 2008;118(25):2748–53. - PubMed
-
- Habib G, Hoen B, Tornos P. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC): Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–41. - PubMed
-
- Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet. 2012;379(9819):965–75. - PubMed
-
- Fragomeni LSM, Vieira FF, Bajerski JCM, Falleiro RP, Hoppen G, Sartori I. Infective endocarditis Surgical Therapy. Arq Bras Cardiol. 2003;80(4):431–7. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical